These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2570861)

  • 1. Hyperglycaemia as a factor affecting kappa-opiate agonist-induced inhibition of the gastrointestinal transit in mice.
    Ramabadran K; Bansinath M; Turndorf H; Puig MM
    J Pharm Pharmacol; 1989 Jul; 41(7):496-8. PubMed ID: 2570861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereospecific inhibition of gastrointestinal transit by kappa opioid agonists in mice.
    Ramabadran K; Bansinath M; Turndorf H; Puig MM
    Eur J Pharmacol; 1988 Oct; 155(3):329-31. PubMed ID: 2853069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kappa-opiate agonist-induced inhibition of gastrointestinal transit in different strains of mice.
    Bansinath M; Ramabadran K; Turndorf H; Puig MM
    Pharmacology; 1991; 42(2):97-102. PubMed ID: 1648236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of kappa- and mu-selective opiate agonists on colonic temperature in normoglycaemic and streptozotocin-treated hyperglycaemic mice.
    Bansinath M; Ramabadran K; Turndorf H; Puig MM
    Pharmacol Toxicol; 1990 May; 66(5):324-8. PubMed ID: 2164667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperglycemia does not modify the pupillary effects of mu and kappa opiate agonists in mice.
    Bansinath M; Ramabadran K; Turndorf H; Puig MM
    J Ocul Pharmacol; 1989; 5(1):33-43. PubMed ID: 2541211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pertussis and cholera toxins modulate kappa-opioid receptor agonists-induced hypothermia and gut inhibition.
    Shukla VK; Turndorf H; Bansinath M
    Eur J Pharmacol; 1995 Mar; 292(3-4):293-9. PubMed ID: 7796869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracerebroventricular administration of kappa-agonists induces convulsions in mice.
    Bansinath M; Ramabadran K; Turndorf H; Shukla VK
    Brain Res Bull; 1991 Jul; 27(1):75-9. PubMed ID: 1657321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orally administered kappa as well as mu opiate agonists delay gastrointestinal transit time in the guinea pig.
    Culpepper-Morgan J; Kreek MJ; Holt PR; LaRoche D; Zhang J; O'Bryan L
    Life Sci; 1988; 42(21):2073-7. PubMed ID: 2838706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Streptozotocin-diabetes attenuates alpha 2-adrenoceptor agonist-induced delay in small intestinal transit in mice.
    Ramabadran K; Bansinath M; Turndorf H; Puig MM
    J Auton Pharmacol; 1990 Jun; 10(3):163-71. PubMed ID: 1974257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperglycaemia is responsible for the inhibited gastrointestinal transit in the early diabetic rat.
    Chang FY; Lee SD; Yeh GH; Wang PS
    Acta Physiol Scand; 1995 Dec; 155(4):457-62. PubMed ID: 8719265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
    Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative studies on the affinities of K-II and U-50488H for kappa opiate receptor].
    Li JG; Ma SC; Lu SN; Wang CQ
    Yao Xue Xue Bao; 1991; 26(1):10-4. PubMed ID: 1653514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of two kappa-opiate agonists, U-50,488H and U-69,593, on the binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to rat spinal cord and amygdala membranes.
    Rahmani NH; Gulati A; Bhargava HN
    Pharmacology; 1991; 43(3):156-62. PubMed ID: 1663623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orally administered opioid antagonists reverse both mu and kappa opioid agonist delay of gastrointestinal transit in the guinea pig.
    Culpepper-Morgan JA; Holt PR; LaRoche D; Kreek MJ
    Life Sci; 1995; 56(14):1187-92. PubMed ID: 7475895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of mu, kappa or delta opioids administered by pellet or pump on oral Salmonella infection and gastrointestinal transit.
    Feng P; Rahim RT; Cowan A; Liu-Chen LY; Peng X; Gaughan J; Meissler JJ; Adler MW; Eisenstein TK
    Eur J Pharmacol; 2006 Mar; 534(1-3):250-7. PubMed ID: 16513108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orally administered kappa but not mu opiate agonists enhance gastric emptying of a solid canned food meal in dogs.
    Gué M; Fioramonti J; Junien JL; Bueno L
    J Pharm Pharmacol; 1988 Dec; 40(12):873-5. PubMed ID: 2907581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the expression of ornithine decarboxylase by some kappa-opioidergic receptor ligands in difluoromethylornithine-resistant L1210 cells.
    Flamigni F; Stefanelli C; Stanic I; Muscari C; Giaccari A; Rossoni C
    Biochim Biophys Acta; 1996 May; 1311(3):204-10. PubMed ID: 8664348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of agonist-induced desensitization of the cloned mouse kappa opioid receptor.
    Raynor K; Kong H; Hines J; Kong G; Benovic J; Yasuda K; Bell GI; Reisine T
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1381-6. PubMed ID: 7932192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of the kappa opioid receptor agonist U-50488H in experimental acute brain and spinal cord injury.
    Hall ED; Wolf DL; Althaus JS; Von Voigtlander PF
    Brain Res; 1987 Dec; 435(1-2):174-80. PubMed ID: 2827851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of behavioral sensitization to cocaine: influence of kappa opioid receptor agonists.
    Heidbreder CA; Babovic-Vuksanovic D; Shoaib M; Shippenberg TS
    J Pharmacol Exp Ther; 1995 Oct; 275(1):150-63. PubMed ID: 7562544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.